Brief: Biohaven Announces Investment Up To $600 Mln By Oberland Capital
28/04/2025 13:12
April 28 (Reuters) - Biohaven Ltd BHVN.N: BIOHAVEN ANNOUNCES INVESTMENT UP TO $600 MILLION BY OBERLAND CAPITAL BIOHAVEN LTD - OBERLAND CAPITAL TO RECEIVE MILESTONE AND ROYALTY PAYMENTS ON NET SALES OF TRORILUZOLE Source text: ID:nPnc6Q9Qa Further company coverage: BHVN.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biohaven
See all newsActing US FDA chief meets with rare disease groups to mend fences (updated)
Acting US FDA chief meets with rare disease groups to mend fences
Brief: Biohaven Reports New Clinical Data In Epilepsy With Opakalim, A Selective Kv7.2/7.3 Activator, Highlighting Seizure Control And Markedly Differentiated Tolerability Profile
Brief: Biohaven Files For Offering Of Up To $350 Million Common Shares - SEC Filing
Brief: Biohaven Ltd Files For Mixed Shelf Offering Size Not Disclosed - SEC Filing